Items where Author is "Farag, Mohamed"

Number of items: 22.
Article
  • Comparison of De-escalation of DAPT Intensity or Duration in East Asian and Western Patients with ACS Undergoing PCI: A Systematic Review and Meta-analysis. (2023) Diana Gorog, Visvesh Jeyalan, Rafaella I. L. Markides, Eliano P Navarese, Young-Hoon Jeong and Mohamed Farag
  • Spontaneous reperfusion in patients with transient ST-elevation myocardial infarction - prevalence, importance and approaches to management. (2021) Mohamed Farag, Marta Peverelli, Nikolaos Spinthakis, Ying X. Gue, Mohaned Egred and Diana Gorog
  • Non-Vitamin K Antagonist Oral Anticoagulants versus Warfarin for Patients with Left Ventricular Thrombus: A Systematic Review and Meta-analysis. (2021) Ying X. Gue, Nikolaos Spinthakis, Mohaned Egred, Diana Gorog and Mohamed Farag
  • Precision treatment in ACS – role of assessing fibrinolysis. (2021) Ying X. Gue, Young-Hoon Jeong, Mohamed Farag, Nikolaos Spinthakis and Diana Gorog
  • Effect of remote ischaemic conditioning on platelet reactivity and endogenous fibrinolysis in ST-elevation myocardial infarction- a substudy of the CONDI-2/ERIC4 PPCI randomised controlled trial. (2020) Diana Gorog, Mohamed Farag, Nikolaos Spinthakis, Derek M. Yellon, Hans E Bøtker†, Rajesh Kharbanda and Derek Hausenloy
  • Impact of Preadmission Morphine on Reinfarction in Patients With ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention : A Meta-Analysis. (2020) Ying Gue, Nikolaos Spinthakis, Mohamed Farag, Jacek Kubica, Jolanta M Siller-Matula, Manivannan Srinivasan and Diana Gorog
  • Relationship of platelet reactivity and inflammatory markers to recurrent adverse events in patients with ST-elevation myocardial infarction. (2019) Krishma Adatia, Mohamed Farag, Ying X. Gue, Manivannan Srinivasan and Diana Gorog
  • Apixaban Enhances Endogenous Fibrinolysis in Patients with Atrial Fibrillation. (2019) Nikolaos Spinthakis, Ying X. Gue, Mohamed Farag, Manivannan Srinivasan, David Wellsted, Gregory Y H Lip, Deepa RJ Arachchillage and Diana Gorog
  • Impaired endogenous fibrinolysis at high shear using a point-of-care test in STEMI is associated with alterations in clot architecture. (2019) Nikolaos Spinthakis, Ying Gue, Mohamed Farag, Guogang Ren, Manivannan Srinivasan, Anwar Baydoun and Diana A Gorog
  • Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events : the RISK PPCI study. (2019) Mohamed Farag, Nikolaos Spinthakis, Ying X. Gue, Manivannan Srinivasan, Keith Sullivan, David Wellsted and Diana A. Gorog
  • Morphine Analgesia Pre-PPCI Is Associated with Prothrombotic State, Reduced Spontaneous Reperfusion and Greater Infarct Size. (2018) Mohamed Farag, Nikolaos Spinthakis, Manivannan Srinivasan, Keith Sullivan, David Wellsted and Diana A Gorog
  • More, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet Therapy-Current Data and Future Directions. (2018) Nikolaos Spinthakis, Mohamed Farag, Bianca Rocca and Diana Gorog
  • Percutaneous coronary intervention with drug-eluting stent versus coronary artery bypass grafting : A meta-analysis of patients with left main coronary artery disease. (2017) Nikolaos Spinthakis, Mohamed Farag, Diana A Gorog, Abhiram Prasad, Hamid Mahmood, Ying Gue, David Wellsted, Ashraf Nabhan and Manivannan Srinivasan
  • Catheter ablation for AF improves global thrombotic profile and enhances fibrinolysis. (2017) Maria Niespialowska-Steuden, Vias Markides, Mohamed Farag, David Jones, Wajid Hussain, Tom Wong and Diana A Gorog
  • Impaired thrombolytic status predicts adverse cardiac events in patients undergoing primary percutaneous coronary intervention. (2017) Christos Christopoulos, Mohamed Farag, Keith Sullivan, David Wellsted and Diana A Gorog
  • Spontaneous Coronary Artery Dissection : The Phantom Menace. (2016) Nikolaos Spinthakis, Nada Abdulkareem, Mohamed Farag and Diana A Gorog
  • Relative effects of different non-vitamin K antagonist oral anticoagulants on global thrombotic status in atrial fibrillation. (2016) Mohamed Farag, Maria Niespialowska-Steuden, Osita Okafor, Benjamin Artman, Manivannan Srinivasan, Arif Khan, Keith Sullivan, David Wellsted and Diana A Gorog
  • Use of bioresorbable vascular scaffold : a meta-analysis of patients with coronary artery disease. (2016) Mohamed Farag, Nikolaos Spinthakis, Diana A Gorog, Abhiram Prasad, Keith Sullivan, Zaki Akhtar, Neville Kukreja and Manivannan Srinivasan
  • Other
  • Reduction or de-escalation of dual antiplatelet therapy intensity or duration in patients with acute coronary syndromes undergoing percutaneous coronary intervention: A mini-review. (2022) Mohamed Farag, Visvesh Jeyalan, Jose Luis Ferreiro, Young-Hoon Jeong, Tobias Geisler and Diana A. Gorog
  • Is there a role for oral triple therapy in patients with acute coronary syndromes without atrial fibrillation? (2018) Nikolaos Spinthakis, Mohamed Farag, Zaki Akhtar and Diana Adrienne Gorog
  • Nitrates for the Management of Acute Heart Failure Syndromes, A Systematic Review. (2017) Mohamed Farag, Ahmad Shoaib and Diana A Gorog
  • Adjunctive therapies to reduce thrombotic events in patients with a history of myocardial infarction : role of vorapaxar. (2015) Mohamed Farag, Hiten Patel and Diana A Gorog